Dymista (azelastine and fluticasone)
What studies of Dymista (azelastine and fluticasone) found
If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.
Ask about this treatment
The grades, in plain words
Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.
- AHelpsImprovement, high certaintyProbably helpsImprovement, moderate certainty
- BMay helpImprovement, low certainty
- CMight help, very uncertainImprovement, very low certaintyMixed resultsStudies disagree
- DLittle or no differenceStudies found little or no difference
- FHarmsIt made things worse
By symptom and daily life
Long COVID
Smell and taste loss1 study · 60 people used Dymista (azelastine and fluticasone) Uncertain –
Why this grade: Uncertain, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (207 in all); helped less than group i (g1), an active treatment; not a sign of harm.
The placebo trial240 randomised · 207 analysed · 3 weeks · 125 µg/50 µg/25 mL actuation nasal spray, one puff in each nostril twice daily
Smell and taste loss improved less than with the comparison treatment.
Dymista (azelastine and fluticasone) helped smell and taste loss less than group i (g1) in the one comparison. Uncertain · very low certainty –
- High risk of bias (RoB 2) in the results that carry most of the weight
- Few people (207 in all)
- Helped less than group i (g1), an active treatment; not a sign of harm
See the 1 study
-
Study of Different Local Treatments of Post COVID-19 Smell Dysfunction. (2022)
- People in the study
- 240 randomised · 207 analysed
- Dose
- 125 µg/50 µg/25 mL actuation nasal spray, one puff in each nostril twice daily
- Outcome
- butanol threshold test
- Effect
- worse
- Risk of bias
RoB 2: High
- Randomisation process
- Low
- Deviations from intended interventions
- High
- Missing outcome data
- High
- Measurement of the outcome
- Low
- Selection of the reported result
- High
Side effects
No study of this treatment alone reported side effects we could read.
All papers
- Study of Different Local Treatments of Post COVID-19 Smell Dysfunction.2022 · placebo trial · 240 randomised · 207 analysed